Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Aimee E. Truesdale"'
1
Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels
Autor: Jacob A. Langness, Zayani Sims, Jennifer J. Kiser, Eric G. Meissner, Aimee E. Truesdale, Leah C. Jimmerson, Thomas J. Urban, Christina L. Aquilante, Fafa Baouchi-Mokrane, Shyam Kottilil, Ariel Hodara
Publikováno v: Journal of clinical pharmacology. 57(1)
Individuals with lower inosine triphosphatase (ITPA) enzyme activity have a reduced likelihood of experiencing hemolytic anemia during hepatitis C virus (HCV) treatment containing ribavirin (RBV). Because ITPA degrades purines and RBV is a purine ana
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd102910e051d297ae23fe77e6b0ef7
https://pubmed.ncbi.nlm.nih.gov/27349952
Zobrazit plný text záznamu
2
Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant
Autor: Stephen H. Caldwell, Aimee E. Truesdale, Patrick G. Northup, Neeral L. Shah, Abdullah M. S. Al-Osaimi, Timothy M. Schmitt, Curtis K. Argo
Publikováno v: Transplant International. 24:991-998
This study compared post-transplant outcomes of patients with hepatocellular carcinoma (HCC) who took sorafenib prior to orthotopic liver transplantation (OLT) with those patients who were not treated with sorafenib. Thirty-three patients with HCC wh
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::360e50cf90c276534d15a7e6190ff0d3
https://doi.org/10.1111/j.1432-2277.2011.01299.x
Zobrazit plný text záznamu
3
Treatment of Chronic Hepatitis C in the Age of Direct-Acting Antivirals with Emphasis on First Generation Inhibitors of HCV NS3/4A Protease
Autor: Gregory T. Everson, Aimee E. Truesdale
Publikováno v: Current Hepatitis Reports. 10:204-213
The past standard-of-care (SOC) for treatment of the chronic hepatitis C virus (HCV) was the combination of peginterferon with ribavirin (P + R). Sustained virologic response (SVR) for patients with HCV, genotype 1, was less than 50%. The new emergin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31dfa5f98caf663139113252f4762042
https://doi.org/10.1007/s11901-011-0107-1
Zobrazit plný text záznamu
4
Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease
Autor: Pamela Mettler, Matthew Quallick, Amanda Wieland, Aimee E. Truesdale, Kiran Bambha
Publikováno v: Digestive diseases and sciences. 58(10)
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. Primary care providers (PCPs), in contrast to gastroenterology/hepatology (GI/Hep) providers, are the first medical contact for the majority of patients with, or at
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eeb348abe07cab706fef25fb81e9312
https://pubmed.ncbi.nlm.nih.gov/23843097
Zobrazit plný text záznamu
6
Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant
Autor: Aimee E, Truesdale, Stephen H, Caldwell, Neeral L, Shah, Curtis K, Argo, Abdullah M S, Al-Osaimi, Timothy M, Schmitt, Patrick G, Northup
Publikováno v: Transplant international : official journal of the European Society for Organ Transplantation. 24(10)
This study compared post-transplant outcomes of patients with hepatocellular carcinoma (HCC) who took sorafenib prior to orthotopic liver transplantation (OLT) with those patients who were not treated with sorafenib. Thirty-three patients with HCC wh
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::218d14a660b56190d61ac86f7f2ccca1
https://pubmed.ncbi.nlm.nih.gov/21910763
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje